DexCom, Inc. (DXCM)Healthcare | Medical Devices | San Diego, United States | NasdaqGS
84.29 USD
-0.77
(-0.905%) ⇩
(Oct. 14, 2026, 11:42 a.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 9:26 a.m. EDT
DexCom's recent earnings beat and FDA approval for AI capabilities have reignited investor enthusiasm, pushing the stock higher despite a technical pullback below its 50-day moving average. The company's fundamentals remain robust, boasting a 38% return on equity and double-digit revenue growth, though the lack of historical price trajectory data limits a full assessment of long-term market validation. Options flow confirms a bullish sentiment, with heavy call open interest clustered around the $95 to $115 strike prices, suggesting traders are positioning for a continued rally. While the valuation is premium, the quality of the business and the strength of the cash flow justify the cost for long-term holders. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.180297 |
| AutoETS | 0.200915 |
| MSTL | 0.202549 |
| AutoTheta | 0.203705 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 38% |
| H-stat | 1.41 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 1.64 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 53.346 |
| Revenue per Share | 12.865 |
| Market Cap | 31,807,739,904 |
| Trailing P/E | 33.45 |
| Forward P/E | 26.99 |
| Beta | 1.48 |
| Profit Margins | 20.12% |
| Website | https://www.dexcom.com |
As of Oct. 10, 2026, 9:26 a.m. EDT: Speculators are positioning for upside momentum with heavy call open interest concentrated between the $95 and $115 strikes, indicating a bullish bias for the near-to-intermediate term. Put open interest is significant at lower strikes ($55-$75), suggesting institutional hedging or downside protection rather than pure bearish aggression. Implied volatility remains elevated across expirations, reflecting uncertainty around the earnings and regulatory catalysts.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.30041277 |
| Address1 | 6,340 Sequence Drive |
| All Time High | 164.8625 |
| All Time Low | 0.34 |
| Ask | 92.0 |
| Ask Size | 1 |
| Audit Risk | 2 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 3,200,100 |
| Average Daily Volume3 Month | 4,413,014 |
| Average Volume | 4,413,014 |
| Average Volume10Days | 3,200,100 |
| Beta | 1.477 |
| Bid | 78.62 |
| Bid Size | 2 |
| Board Risk | 7 |
| Book Value | 6.946 |
| City | San Diego |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 5 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 84.29 |
| Current Ratio | 1.733 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 86.18 |
| Day Low | 83.59 |
| Debt To Equity | 53.346 |
| Display Name | DexCom |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,793,304,000 |
| Earnings Call Timestamp Start | 1,793,304,000 |
| Earnings Growth | 0.436 |
| Earnings Quarterly Growth | 0.385 |
| Earnings Timestamp | 1,793,304,000 |
| Earnings Timestamp End | 1,793,304,000 |
| Earnings Timestamp Start | 1,793,304,000 |
| Ebitda | 1,403,200,000 |
| Ebitda Margins | 0.28238 |
| Enterprise To Ebitda | 22.484 |
| Enterprise To Revenue | 6.349 |
| Enterprise Value | 31,549,706,240 |
| Eps Current Year | 2.66305 |
| Eps Forward | 3.12344 |
| Eps Trailing Twelve Months | 2.52 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 87.4536 |
| Fifty Day Average Change | -3.163597 |
| Fifty Day Average Change Percent | -0.03617458 |
| Fifty Two Week Change Percent | 30.041277 |
| Fifty Two Week High | 92.59 |
| Fifty Two Week High Change | -8.299995 |
| Fifty Two Week High Change Percent | -0.089642465 |
| Fifty Two Week Low | 54.11 |
| Fifty Two Week Low Change | 30.18 |
| Fifty Two Week Low Change Percent | 0.5577527 |
| Fifty Two Week Range | 54.11 - 92.59 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,113,485,400,000 |
| Float Shares | 375,998,493 |
| Forward Eps | 3.12344 |
| Forward P E | 26.98627 |
| Free Cashflow | 1,021,162,496 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 11,000 |
| Fullday Change | -0.76999664 |
| Fullday Change Percent | -0.90523946 |
| Fullday Price | 84.29 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.62473 |
| Gross Profits | 3,104,399,872 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00262 |
| Held Percent Institutions | 1.0654399 |
| Implied Shares Outstanding | 377,360,765 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ir Website | http://www.dexcom.com/about-dexcom/investor-relations |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,655,078,400 |
| Last Split Factor | 4:1 |
| Long Business Summary | DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California. |
| Long Name | DexCom, Inc. |
| Market | us_market |
| Market Cap | 31,807,739,904 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_114039 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 999,699,968 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 33,105,859,913 |
| Number Of Analyst Opinions | 26 |
| Open | 85.89 |
| Operating Cashflow | 1,748,700,032 |
| Operating Margins | 0.24327 |
| Overall Risk | 5 |
| Payout Ratio | 0.0 |
| Peg Ratio | 2.12 |
| Phone | 858 200 0200 |
| Previous Close | 85.06 |
| Price Eps Current Year | 31.651678 |
| Price Hint | 2 |
| Price To Book | 12.135041 |
| Price To Sales Trailing12 Months | 6.4009776 |
| Profit Margins | 0.20118 |
| Quick Ratio | 1.37 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.34483 |
| Region | US |
| Regular Market Change | -0.76999664 |
| Regular Market Change Percent | -0.90523946 |
| Regular Market Day High | 86.18 |
| Regular Market Day Low | 83.59 |
| Regular Market Day Range | 83.59 - 86.18 |
| Regular Market Open | 85.89 |
| Regular Market Previous Close | 85.06 |
| Regular Market Price | 84.29 |
| Regular Market Time | 1,791,992,566 |
| Regular Market Volume | 785,866 |
| Return On Assets | 0.103310004 |
| Return On Equity | 0.38491002 |
| Revenue Growth | 0.131 |
| Revenue Per Share | 12.865 |
| Sand P52 Week Change | 0.17004645 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 6 |
| Shares Outstanding | 377,360,765 |
| Shares Percent Shares Out | 0.037100002 |
| Shares Short | 14,017,639 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 17,626,435 |
| Short Name | DexCom, Inc. |
| Short Percent Of Float | 0.0429 |
| Short Ratio | 3.52 |
| Source Interval | 15 |
| State | CA |
| Symbol | DXCM |
| Target High Price | 115.0 |
| Target Low Price | 79.0 |
| Target Mean Price | 96.46154 |
| Target Median Price | 95.0 |
| Total Cash | 1,947,000,064 |
| Total Cash Per Share | 5.16 |
| Total Debt | 1,398,400,000 |
| Total Revenue | 4,969,200,128 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 2.52 |
| Trailing P E | 33.448414 |
| Trailing Peg Ratio | 1.3487 |
| Triggerable | 1 |
| Two Hundred Day Average | 73.6913 |
| Two Hundred Day Average Change | 10.5987015 |
| Two Hundred Day Average Change Percent | 0.14382568 |
| Type Disp | Equity |
| Volume | 785,866 |
| Website | https://www.dexcom.com |
| Zip | 92,121 |